Mey, L.; Bonaterra, G.A.; Hoffmann, J.; Schwarzbach, H.; Schwarz, A.; Eiden, L.E.; Weihe, E.; Kinscherf, R.
PAC1 Agonist Maxadilan Reduces Atherosclerotic Lesions in Hypercholesterolemic ApoE-Deficient Mice. Int. J. Mol. Sci. 2024, 25, 13245.
https://doi.org/10.3390/ijms252413245
AMA Style
Mey L, Bonaterra GA, Hoffmann J, Schwarzbach H, Schwarz A, Eiden LE, Weihe E, Kinscherf R.
PAC1 Agonist Maxadilan Reduces Atherosclerotic Lesions in Hypercholesterolemic ApoE-Deficient Mice. International Journal of Molecular Sciences. 2024; 25(24):13245.
https://doi.org/10.3390/ijms252413245
Chicago/Turabian Style
Mey, Lilli, Gabriel A. Bonaterra, Joy Hoffmann, Hans Schwarzbach, Anja Schwarz, Lee E. Eiden, Eberhard Weihe, and Ralf Kinscherf.
2024. "PAC1 Agonist Maxadilan Reduces Atherosclerotic Lesions in Hypercholesterolemic ApoE-Deficient Mice" International Journal of Molecular Sciences 25, no. 24: 13245.
https://doi.org/10.3390/ijms252413245
APA Style
Mey, L., Bonaterra, G. A., Hoffmann, J., Schwarzbach, H., Schwarz, A., Eiden, L. E., Weihe, E., & Kinscherf, R.
(2024). PAC1 Agonist Maxadilan Reduces Atherosclerotic Lesions in Hypercholesterolemic ApoE-Deficient Mice. International Journal of Molecular Sciences, 25(24), 13245.
https://doi.org/10.3390/ijms252413245
